Cargando…

Proof-of-concept study linking ex vivo sensitivity testing to neoadjuvant anthracycline-based chemotherapy response in breast cancer patients

We developed a functional ex vivo anthracycline-based sensitivity test. Surgical resection material of primary breast cancer (BC) was used to determine criteria for the ex vivo sensitivity assay based on morphology, proliferation and apoptosis. Subsequently, a proof-of-concept study was performed co...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ladan, Marjolijn M., Meijer, Titia G., Verkaik, Nicole S., de Monye, Cecile, Koppert, Linetta B., Oomen-de Hoop, Esther, van Deurzen, Carolien H. M., Kanaar, Roland, Nonnekens, Julie, van Gent, Dik C., Jager, Agnes
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10542784/ https://www.ncbi.nlm.nih.gov/pubmed/37777518 http://dx.doi.org/10.1038/s41523-023-00583-6

Ejemplares similares

Functional Ex Vivo Tissue-Based Chemotherapy Sensitivity Testing for Breast Cancer
por: Ladan, Marjolijn M., et al.
Publicado: (2022)

Functional RECAP (REpair CAPacity) assay identifies homologous recombination deficiency undetected by DNA-based BRCAness tests
por: Meijer, Titia G., et al.
Publicado: (2022)

Homologous Recombination Deficiency Testing for BRCA-Like Tumors: The Road to Clinical Validation
por: Ladan, Marjolijn M., et al.
Publicado: (2021)

Ex vivo treatment of prostate tumor tissue recapitulates in vivo therapy response
por: Zhang, Wenhao, et al.
Publicado: (2018)

Tumor slice culture system to assess drug response of primary breast cancer
por: Naipal, Kishan A. T., et al.
Publicado: (2016)

A retrospective alternative for active surveillance trials for ductal carcinoma in situ of the breast
por: Van Bockstal, Mieke R., et al.
Publicado: (2019)

Ex vivo tumor culture systems for functional drug testing and therapy response prediction
por: Meijer, Titia G, et al.
Publicado: (2017)

Gamma probe and ultrasound guided fine needle aspiration cytology of the sentinel node (GULF) trial - overview of the literature, pilot and study protocol
por: Oude Ophuis, Charlotte M.C., et al.
Publicado: (2017)

Exploiting DNA repair defects for novel cancer therapies
por: van Gent, Dik C., et al.
Publicado: (2016)

Extent of ductal carcinoma in situ according to breast cancer subtypes: a population-based cohort study
por: Doebar, Shusma C., et al.
Publicado: (2016)

Radioactive Seed Versus Wire-Guided Localization for Ductal Carcinoma in Situ of the Breast: Comparable Resection Margins
por: Agahozo, Marie Colombe, et al.
Publicado: (2020)

Erratum to: gamma probe and ultrasound guided fine needle aspiration cytology of the sentinel node (GULF) trial - overview of the literature, pilot and study protocol
por: Oude Ophuis, Charlotte M.C., et al.
Publicado: (2017)

Preclinical Assessment of the Combination of PSMA-Targeting Radionuclide Therapy with PARP Inhibitors for Prostate Cancer Treatment
por: Ruigrok, Eline A. M., et al.
Publicado: (2022)

Triple-Negative Breast Cancer and Predictive Markers of Response to Neoadjuvant Chemotherapy: A Systematic Review
por: van den Ende, Nadine S., et al.
Publicado: (2023)

Role of the DNA damage response in prostate cancer formation, progression and treatment
por: Zhang, Wenhao, et al.
Publicado: (2019)

Correction to: Role of the DNA damage response in prostate cancer formation, progression and treatment
por: Zhang, Wenhao, et al.
Publicado: (2019)

HSF2BP negatively regulates homologous recombination in DNA interstrand crosslink repair
por: Sato, Koichi, et al.
Publicado: (2020)

Anthracyclines versus No Anthracyclines in the Neoadjuvant Strategy for HER2+ Breast Cancer: Real-World Evidence
por: de Pinho, Inês Soares, et al.
Publicado: (2023)

The role of DNA dependent protein kinase in synapsis of DNA ends
por: Weterings, Eric, et al.
Publicado: (2010)

Gamma probe and ultrasound-guided fine needle aspiration cytology of the sentinel node (GULF) trial
por: Verver, Daniëlle, et al.
Publicado: (2018)

Apalutamide Sensitizes Prostate Cancer to Ionizing Radiation via Inhibition of Non-Homologous End-Joining DNA Repair
por: Zhang, Wenhao, et al.
Publicado: (2019)

Diagnostic Accuracy of Different Surgical Procedures for Axillary Staging After Neoadjuvant Systemic Therapy in Node-positive Breast Cancer: A Systematic Review and Meta-analysis
por: Simons, Janine M., et al.
Publicado: (2019)

Low dose ionizing radiation strongly stimulates insertional mutagenesis in a γH2AX dependent manner
por: Zelensky, Alex N., et al.
Publicado: (2020)

Effect of anthracyclin-based neoadjuvant chemotherapy on disseminated tumor cells in breast cancer patients: an immunocytologic and molecular approach
por: Jäger, CM, et al.
Publicado: (2001)

Potentiation of Peptide Receptor Radionuclide Therapy by the PARP Inhibitor Olaparib
por: Nonnekens, Julie, et al.
Publicado: (2016)

DNA Damage-Inducing Anticancer Therapies: From Global to Precision Damage
por: Reuvers, Thom G. A., et al.
Publicado: (2020)

Attenuated XPC Expression Is Not Associated with Impaired DNA Repair in Bladder Cancer
por: Naipal, Kishan A. T., et al.
Publicado: (2015)

Ex vivo assays to predict enhanced chemosensitization by hyperthermia in urothelial cancer of the bladder
por: van den Tempel, Nathalie, et al.
Publicado: (2018)

The Prevalence of CD146 Expression in Breast Cancer Subtypes and Its Relation to Outcome
por: de Kruijff, Ingeborg E., et al.
Publicado: (2018)

C-Terminal Extensions of Ku70 and Ku80 Differentially Influence DNA End Binding Properties
por: Inagawa, Takabumi, et al.
Publicado: (2020)

Predictors of Surgical Margin Following Breast-Conserving Surgery: A Large Population-Based Cohort Study
por: van Deurzen, Carolien H. M.
Publicado: (2016)

Clinical and Pathological Response to Neoadjuvant Anthracycline Based Chemotherapy in women with breast cancer
por: Olfa, Gharbi, et al.
Publicado: (2010)

Opportunities for personalised follow‐up care among patients with breast cancer: A scoping review to identify preference‐sensitive decisions
por: de Ligt, Kelly M., et al.
Publicado: (2019)

A preliminary prediction model for potentially guiding patient choices between breast conserving surgery and mastectomy in early breast cancer patients; a Dutch experience
por: Vos, Elvira, et al.
Publicado: (2017)

Machine learning with PROs in breast cancer surgery; caution: Collecting PROs at baseline is crucial
por: van Egdom, Laurentine S. E., et al.
Publicado: (2020)

Bilateral prophylactic mastectomy: should we preserve the pectoral fascia? Protocol of a Dutch double blinded, prospective, randomised controlled pilot study with a within-subject design (PROFAS)
por: Clarijs, Marloes E, et al.
Publicado: (2023)

Chromosome 17 Centromere Duplication and Responsiveness to Anthracycline-Based Neoadjuvant Chemotherapy in Breast Cancer()()
por: Tibau, Ariadna, et al.
Publicado: (2014)

A MicroRNA Expression Signature In Taxane-anthracycline-based Neoadjuvant Chemotherapy Response
por: Zheng, Yi, et al.
Publicado: (2015)

Measuring Quality of Life Using Patient-Reported Outcomes in Real-World Metastatic Breast Cancer Patients: The Need for a Standardized Approach
por: Clarijs, Marloes E., et al.
Publicado: (2021)

Omitting re-excision for focally positive margins after breast-conserving surgery does not impair disease-free and overall survival
por: Vos, Elvira L., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_birn4dfpbab4go48n9hjg21v57